Vera Therapeutics Inc. VERA
$33.30
▲ +1.81% 24H
About
Vera Therapeutics Inc. is a biotechnology company engaged in the research and development of transformative therapies aimed at treating immune-mediated diseases. The primary focus of Vera Therapeutics is to address unmet medical needs, particularly in the treatment of conditions such as immunoglobulin A nephropathy (Ig…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees339
TickerVERA
Statistics
Market Cap$2.39B
Revenue (TTM)$0
Net Income-$299.6M
Net Margin—
EPS$-4.66
P/E-7.21
P/S—
P/B4.57
EV/EBITDA-4.61
ROE-71.3%
Dividend Yield—
Price$33.30
Data: Twelve Data · Revenue = mcap / P/S